InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.590
-0.010 (-0.38%)
Apr 25, 2025, 4:00 PM EDT - Market closed
InspireMD Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for InspireMD stock have an average target of 4.75, with a low estimate of 4.50 and a high estimate of 5.00. The average target predicts an increase of 83.40% from the current stock price of 2.59.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 11, 2024.
Analyst Ratings
The average analyst rating for InspireMD stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Lake Street | Lake Street | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +93.05% | Dec 11, 2024 |
Piper Sandler | Piper Sandler | Buy Reiterates $4.5 | Buy | Reiterates | $4.5 | +73.75% | Sep 17, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $3.5 → $4.5 | Buy | Maintains | $3.5 → $4.5 | +73.75% | Nov 2, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates $3 | Buy | Initiates | $3 | +15.83% | Jun 12, 2023 |
National Alliance Securities | National Alliance Securities | Strong Buy Maintains $5.15 → $4.75 | Strong Buy | Maintains | $5.15 → $4.75 | +83.40% | May 17, 2023 |
Financial Forecast
Revenue This Year
9.04M
from 7.01M
Increased by 28.93%
Revenue Next Year
24.60M
from 9.04M
Increased by 172.18%
EPS This Year
-0.91
from -0.76
EPS Next Year
-0.76
from -0.91
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 10.0M | 26.1M | 50.7M |
Avg | 9.0M | 24.6M | 49.2M |
Low | 8.1M | 22.9M | 47.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 42.3% | 188.5% | 106.0% |
Avg | 28.9% | 172.2% | 100.1% |
Low | 14.9% | 153.8% | 92.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.83 | -0.51 | -0.41 |
Avg | -0.91 | -0.76 | -0.40 |
Low | -0.98 | -0.98 | -0.38 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.